P2RY6 and clostridium difficile infection: Although our data suggest that targeting the P2Y6 receptor may prove effective in the treatment of CDI, it is important to note that its ubiquitous expression will require targeted delivery of any therapeutic agent into the gastrointestinal tract with little systemic absorption.